Dr. Michio Hirano, MD

Dr. Hirano practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Hirano's NPI, 1508873969, was assigned on August 1, 2006. Dr. Hirano graduated from Albert Einstein College of Medicine of Yeshiva University in 1986. Dr. Hirano holds New York license 172511-1.

Dr. Hirano's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Hirano's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Hirano is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Hirano to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hirano practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hirano's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hirano is licensed in New York.

CMS data shows 95 Medicare services from Dr. Hirano across 2 procedure codes in 2024, for 54 Medicare patients. Medicare paid $7,815 for them. Every service was in an office.

CMS counts 54 Medicare patients who saw Dr. Hirano in 2024. The largest group is under 65, with 21 patients. 72% of them have high cholesterol, and 63% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hirano's median patient age at 45, with 49% women.

In 2024, Dr. Hirano wrote 294 Medicare Part D claims for 33 patients. 62% of them were for generic drugs. CMS names the drug for 188 of them, across 11 drugs with 11 or more claims each, at $1,056,925 in total drug cost. In 2023, CMS named 183 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hirano for performance year 2024, reported through an alternative payment model (APM). Dr. Hirano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hirano as offering telehealth.

Dmand AI links 23 papers to Dr. Hirano, published from 2011 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Mitochondrial Diseases, Spinal Muscular Atrophies of Childhood and Disease Progression. Dr. Hirano has published most often in medRxiv. Dr. Hirano's most frequent co-authors are Basil T. Darras, MD, Richard Sanford Finkel, MD and John West Day, MD.

CMS Open Payments shows 77 general payments to Dr. Hirano from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 88% of the total. UCB, Inc. paid the most, $60,797. It also lists 21 research payments totaling $319,583 from 2023 to 2025.

Dr. Hirano graduated from Albert Einstein College of Medicine of Yeshiva University in 1986.